![Boehringer Ingelheim Receives FDA Approval for NexGard® PLUS (afoxolaner, moxidectin and pyrantel chewable tablets): A Beef-Flavored Soft Chew That Protects Dogs from Internal and External Parasites | Boehringer Ingelheim Animal Health Boehringer Ingelheim Receives FDA Approval for NexGard® PLUS (afoxolaner, moxidectin and pyrantel chewable tablets): A Beef-Flavored Soft Chew That Protects Dogs from Internal and External Parasites | Boehringer Ingelheim Animal Health](https://bi-animalhealth.com/sites/default/files/2023-06/NexGard%20PLUS%2016x9.png)
Boehringer Ingelheim Receives FDA Approval for NexGard® PLUS (afoxolaner, moxidectin and pyrantel chewable tablets): A Beef-Flavored Soft Chew That Protects Dogs from Internal and External Parasites | Boehringer Ingelheim Animal Health
![SIMPARICA TRIO Chewable Tablet for Dogs, 44.1-88 lbs, (Green Box), 12 Chewable Tablets (12-mos. supply) - Chewy.com SIMPARICA TRIO Chewable Tablet for Dogs, 44.1-88 lbs, (Green Box), 12 Chewable Tablets (12-mos. supply) - Chewy.com](https://image.chewy.com/is/image/catalog/296724_MAIN._AC_SL600_V1623858449_.jpg)
SIMPARICA TRIO Chewable Tablet for Dogs, 44.1-88 lbs, (Green Box), 12 Chewable Tablets (12-mos. supply) - Chewy.com
![ADVANTAGE MULTI Topical Solution for Dogs, 20.1-55 lbs, (Red Box), 6 Doses (6-mos. supply) - Chewy.com ADVANTAGE MULTI Topical Solution for Dogs, 20.1-55 lbs, (Red Box), 6 Doses (6-mos. supply) - Chewy.com](https://image.chewy.com/is/image/catalog/146318_MAIN._AC_SL1500_V1683646196_.jpg)
ADVANTAGE MULTI Topical Solution for Dogs, 20.1-55 lbs, (Red Box), 6 Doses (6-mos. supply) - Chewy.com
![Moxidectin: heartworm disease prevention in dogs in the face of emerging macrocyclic lactone resistance | Parasites & Vectors | Full Text Moxidectin: heartworm disease prevention in dogs in the face of emerging macrocyclic lactone resistance | Parasites & Vectors | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13071-021-05104-7/MediaObjects/13071_2021_5104_Figa_HTML.png)
Moxidectin: heartworm disease prevention in dogs in the face of emerging macrocyclic lactone resistance | Parasites & Vectors | Full Text
![Field safety and efficacy of an orally administered combination of sarolaner, moxidectin and pyrantel (Simparica Trio®) for the prevention of angiostrongylosis in dogs presented as veterinary patients | Parasites & Vectors Field safety and efficacy of an orally administered combination of sarolaner, moxidectin and pyrantel (Simparica Trio®) for the prevention of angiostrongylosis in dogs presented as veterinary patients | Parasites & Vectors](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13071-020-04262-4/MediaObjects/13071_2020_4262_Figa_HTML.png)